Somewhat counterintuitively to frequentists, this is not a problem if they did Bayesian analysis. Many new trails for COVID19 therapeutics are actually reporting realtime Bayesian estimates of efficacy.
https://www.pwc.com/us/en/industries/health-industries/libra...